Cargando…
SARS‐CoV‐2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage
SARS‐CoV‐2 is an emerging coronavirus that causes dysfunctions in multiple human cells and tissues. Studies have looked at the entry of SARS‐CoV‐2 into host cells mediated by the viral spike protein and human receptor ACE2. However, less is known about the cellular immune responses triggered by SARS...
Autores principales: | Ma, Juan, Zhu, Fangrui, Zhao, Min, Shao, Fei, Yu, Dou, Ma, Jiangwen, Zhang, Xusheng, Li, Weitao, Qian, Yan, Zhang, Yan, Jiang, Dong, Wang, Shuo, Xia, Pengyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420271/ https://www.ncbi.nlm.nih.gov/pubmed/34296442 http://dx.doi.org/10.15252/embj.2021108249 |
Ejemplares similares
-
Gasdermin D in pyroptosis
por: Burdette, Brandon E., et al.
Publicado: (2021) -
Pyroptosis inhibiting nanobodies block Gasdermin D pore formation
por: Kopp, Anja, et al.
Publicado: (2023) -
Novel pyroptosis-independent functions of gasdermins
por: Qin, Ziran, et al.
Publicado: (2022) -
Pyroptosis, inflammasome, and gasdermins in tumor immunity
por: Ouyang, Xiaohu, et al.
Publicado: (2023) -
FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation
por: Hu, Jun Jacob, et al.
Publicado: (2020)